ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL by Taiwo, Babafemi O, Zheng, Lu, Stefanescu, Andrei, Nyaku, Amesika, Bezins, Baiba, Wallis, Carole L, Godfrey, Catherine, Sax, Paul E, Acosta, Edward, Haas, David, Smith, Kimberly Y, Sha, Beverly, Van Dam, Cornelius, Gulick, Roy M

Get full text